Análisis

While a weak won usually boosts exporters, pharma and biotech firms see mixed effects as foreign revenue growth is offset by rising foreign‑currency costs for raw materials, debt and liabilities.

Kimball Electronics announced plans to grow its life‑science contract manufacturing capabilities through acquisitions in Europe and India.